1. Association between polypharmacy and cognitive impairment in older adults: A systematic review and meta-analysis.
- Author
-
Yu, Xiaoyun, Qian, Ying, Zhang, Yudie, Chen, Ying, and Wang, Min
- Abstract
• Risk of cognitive impairment was higher in older adults taking ≥5 medications. • Risk of cognitive impairment was even higher in those taking ≥10 medications. • Risk of cognitive impairment was higher in Asian countries than in other countries. • Risk of cognitive impairment was higher in nursing home residents than in others. • Clinicians should conduct medication reviews and use non-pharmacological therapy. This meta-analysis explored the relationship between polypharmacy and cognitive impairment in older adults. We systematically searched for observational studies on polypharmacy and cognitive impairment in the Cochrane Library, PubMed, Web of Science, Embase, and CINAHL databases and performed meta-analysis to pool the study results using fixed- or random-effects models. The quality of evidence was assessed using the Grading of Recommendations, Assessment Development, and Evaluation system. Twenty-seven studies involving 124,452,121 older adults aged >60 years were included. These studies showed that the risk of cognitive impairment was significantly increased in older adults with polypharmacy (≥5 medications) (OR = 1.39, 95% CI: 1.23–1.58, P < 0.001) and in those with excessive polypharmacy (≥10 medications) (OR = 1.51, 95% CI: 1.01–2.25, P = 0.042). This study suggests a potential association between polypharmacy and cognitive impairment in older adults. However, the causal relationship requires further verification. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF